Abstract
Fatty acid-binding protein 7 (FABP7) is vital for uptake and trafficking of fatty acids in the nervous system. To investigate the involvement of FABP7 in noise-induced hearing loss (NIHL) pathogenesis, we used Fabp7 knockout (KO) mice generated via CRISPR/Cas9 in the C57BL/6 background. Initial auditory brainstem response (ABR) measurements were conducted at 9 weeks, followed by noise exposure at 10 weeks. Subsequent ABRs were performed 24 h later, with final measurements at 12 weeks. Inner ears were harvested 24 h after noise exposure for RNA sequencing and metabolic analyses. We found no significant differences in initial ABR measurements, but Fabp7 KO mice showed significantly lower thresholds in the final ABR measurements. Hair cell survival was also enhanced in Fabp7 KO mice. RNA sequencing revealed that genes associated with the electron transport chain were upregulated or less impaired in Fabp7 KO mice. Metabolomic analysis revealed various alterations, including decreased glutamate and aspartate in Fabp7 KO mice. In conclusion, FABP7 deficiency mitigates cochlear damage following noise exposure. This protective effect was supported by the changes in gene expression of the electron transport chain, and in several metabolites, including excitotoxic neurotransmitters. Our study highlights the potential therapeutic significance of targeting FABP7 in NIHL.
Similar content being viewed by others
Introduction
Noise-induced hearing loss (NIHL) is a sensorineural hearing impairment caused by acute, single, chronic, or repeated exposure to loud sounds. While chronic occupational noise exposure is an important cause of NIHL, nonoccupational noise from residential and recreational activities has recently attracted attention as a contributing factor to NIHL1,2,3. According to a recent systematic review, more than 1 billion young people are at risk of hearing loss due to unsafe listening practices such as using personal listening devices and attending loud entertainment venues4. A recent study reported the deterioration of hearing thresholds at 1000, 2000, and 4000 Hz among the younger generation during the later decade (2010–2020) compared to those in the former decade (2000–2010). This suggests that NIHL may explain the observed changes5. Preventative measures, such as reducing noise volume, limiting exposure time, and wearing hearing protection, are crucial in mitigating the risk of NIHL2. However, despite their importance, these preventive methods are not widely practiced. Hence, there is an increasing demand for prophylactic and therapeutic drugs for NIHL6, since no established medication is available for humans.
The pathogenesis of NIHL is complex and involves both genetic and environmental factors2,7,8. Although various factors, such as oxidative stress, inflammation, and glutamate excitotoxicity, have been proposed as crucial contributors to NIHL development in mammals, the underlying molecular mechanisms are not yet fully understood2,7,9,10. The excessive generation of reactive oxygen species (ROS) is widely acknowledged as a mediator of noise-induced cochlear damage, and ROS-induced lipid peroxidation products can induce apoptosis, resulting in the permanent loss of auditory sensory cells in the cochlea7. Polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA) and arachidonic acid (ARA), affect many physiological processes and are particularly susceptible to oxidation because of their high degrees of unsaturation, and their oxidized products can exert toxic effects11. Previous studies found that genetic enrichment or dietary supplementation with n-3 PUFA slows the progression of age-related hearing loss (AHL) in mice12,13. Moreover, the intake of n-3 PUFAs or the consumption of fish is inversely correlated with AHL progression14, and an inverse correlation exists between plasma n-3 PUFA levels and AHL progression in humans15. However, a perinatal diet supplemented with high levels of DHA or n-3 PUFAs may harm the auditory system in rats16,17. Therefore, the precise role of PUFAs in hearing remains inconclusive12,13,14,15,16,17,18,19,20. To our knowledge, no previous studies have investigated the relationship between the pathology of NIHL and PUFAs.
PUFAs are hydrophobic molecules that bind to fatty acid-binding proteins (FABPs) in the aqueous cytoplasm. FABPs play crucial roles in facilitating the cellular uptake and intracellular trafficking of fatty acids, thereby regulating metabolic pathways and gene expression21,22,23. Among the FABP family, FABP7 exhibits preferential binding affinity to n-3 PUFAs, particularly DHA, and contributes to cell membrane production and synaptic vesicles22. FABP7 also attracts attention as a regulator of cell signaling in tumors such as glioma, melanoma, and renal cancer24. The expressions of FABP3 and FABP7 differ significantly in the mouse cochlea. FABP3 is specifically expressed in spiral ganglion (SG) neurons and supporting cells within the organ of Corti (OC), whereas FABP7 is predominantly found in non-hair cells and non-neuronal cells, including supporting cells in the OC, fibrocytes in the spiral limbus (SLim) and spiral ligament (SLig), and satellite cells in the SG25,26,27. Fabp3 deficiency does not affect auditory function27. Our previous study involving Fabp7 knockout (KO) C57BL/6 mice, generated using embryonic stem cells of the 129/Sv background, suggested a delay in the progression of age-related hearing loss in these mice26. However, subsequent findings revealed that these Fabp7 KO mice possess a normal Cdh23753G allele derived from the 129/Sv strain, raising uncertainty as to whether Fabp7 deficiency alone is responsible for the observed hearing-protective phenotype26. Therefore, this study aimed to investigate the effects of Fabp7 deficiency on hearing following noise exposure by evaluating Fabp7-KO mice on a C57BL/6 background, established via the CRISPR-Cas9 system16,28.
Results
Fabp7 KO mice showed normal growth in standard environmental conditions
Wild-type (WT) (n = 8) and Fabp7 KO mice (n = 8) were weighed at 9 and 12 weeks of age, to evaluate the effects of Fabp7 deletion on body weight (Fig. 1A). There were no significant differences in body weights between the two groups at any time point during the experiment (Fig. 1B). These results indicate that Fabp7 deletion has no effect on body weight in the youth during growth stages.
To confirm that the newly designed Fabp7 KO mice had a single nucleotide polymorphism in the Cdh23 gene (Cdh23753A) on chromosome 10, which is the most critical genetic variant causing hearing loss in the C57BL/6 strain26, we performed sequence analysis of 5 mice per group (Fig. 1A). All the WT and Fabp7 KO mice examined had the Cdh23753A genotype (Supplementary Fig. 1), suggesting that the mice examined in this study had a WT genetic background of Cdh23.
Next, we assessed FABP7 expression in the cochleae of WT and Fabp7 KO mice by immunohistochemistry of frozen sections to investigate whether FABP7 expression was completely absent in the cochlea of Fabp7 KO mice (Fig. 1A). As expected, we confirmed the presence of FABP7 in various cell types, such as Schwann cells and supporting cells in the OC, satellite cells in the SG, fibrocytes in the SLim and SLig, in the cochlea of WT mice in a similar pattern to previous reports25,26 (Fig. 1C,E,F). Furthermore, we confirmed the complete loss of FABP7 expression in the cochlea of Fabp7 KO mice established via the CRISPR-Cas9 system (Fig. 1D).
Fabp7 deletion protects from hearing deterioration after noise exposure
To address whether Fabp7 deficiency affects susceptibility to noise exposure causing moderate permanent threshold shift (PTS, approximately 50 dB sound pressure level (SPL)), auditory brainstem response (ABR) thresholds of WT mice (n = 8) and Fabp7 KO mice (n = 8) were examined before and after exposure to 8–16 kHz octave-band noise at 100 dB SPL for 2 h (Fig. 1A). The ABR thresholds before and at post-noise exposure day (PNED) 1 were not significantly different between the WT and Fabp7 KO mice (Fig. 2A,B), indicating that FABP7 is not crucial for normal development and function of the cochlea and protection from initial cochlear damage after noise exposure. However, the ABR thresholds at 8, 12, and 32 kHz in Fabp7 KO mice at PNED 14 were significantly lower than those in WT mice (Fig. 2C). These results suggested that Fabp7 deletion protected against permanent hearing deterioration after exposure to noise causing moderate PTS in mice.
Fabp7 deletion protects loss of hair cells after noise exposure
Noise exposure causes various types of cochlear damages including loss of important cells such as hair cells and SG neurons, and atrophy of tissues such as a stria vascularis (SV). To clarify the morphological basis of the protective effect of Fabp7 deletion, histological examinations were performed using cochlear wholemounts and paraffin sections for WT mice (n = 8) and Fabp7 KO mice (n = 7) after final ABR measurements (Fig. 1A). The inner hair cells (IHCs) and outer hair cells (OHCs) were counted using whole mounts stained with rhodamine-conjugated phalloidin (Fig. 3A,B). Quantitative analyses revealed that OHC survival at 32 and 45.2 kHz regions and IHC survival at 45.2 kHz region were significantly higher in Fabp7 KO mice than those in the WT mice (Fig. 3C,D). The number of SG neurons and type-4 fibrocytes, as well as SV thickness were evaluated using cochlear coronal paraffin sections (Fig. 3E,F). No significant differences in SG neuron survival, type-4 fibrocyte survival, or SV thickness were observed after noise exposure between WT and Fabp7 KO mice (Fig. 3G–I). These results suggested that Fabp7 deletion protected against hair cell loss after noise exposure at high frequencies, supporting the results of ABR measurements.
Lipid peroxidation product is affected by Fabp7 deletion
To evaluate oxidative damage in the cochlea after noise exposure, we semi-quantified the immunoreactivities of 4-Hydroxy-2-nonenal (4-HNE), a major product of lipid peroxidation29 and 4-hydroxy hexenal (4-HHE), a lipid peroxidation product derived from oxidized n-3 fatty acids, such as DHA30 (Fig. 1A). We assessed 4-HNE and 4-HHE expression in the OC and SG of WT mice (n = 3) without noise exposure and in WT (n = 3) and Fabp7 KO mice (n = 4) one day after noise exposure at 10 weeks of age (Fig. 4A–F). Quantitative analysis indicated that 4-HNE immunofluorescence in the OC and SG (Fig. 4G,H) and 4-HHE immunofluorescence in the OC (Fig. 4I) did not differ significantly among the three groups. In contrast, 4-HHE immunofluorescence in the SG was significantly higher in noise-exposed WT mice than in control WT mice, but not in noise-exposed Fabp7 KO mice (Fig. 4J). Thus, expression of the oxidized n-3 fatty acid-mediated lipid peroxidation product was affected by Fabp7 deletion.
Transcriptome analysis of differentially expressed genes in the WT and Fabp7 KO mouse inner ear
To elucidate the function of FABP7 in the inner ear, particularly in the context of its protective mechanisms against noise-induced trauma, we evaluated gene expressions between WT (n = 3) and Fabp7 KO mice (n = 3) one day after noise exposure, using RNA sequencing analysis (Fig. 1A). The read number was approximately 27–32 million paired-end reads per sample. A total of 24 and 23 genes were identified as upregulated and downregulated differentially expressed genes (DEGs), respectively, in Fabp7 KO mice (Supplementary Tables 1 and 2). Notably, the upregulation of genes related to nicotinamide-adenine dinucleotide (NADH) dehydrogenase (mt-Nd1, 2, 3, 4, and 6) and a glial high-affinity glutamate transporter (solute carrier family 1, member 2: Slc1a2) and downregulation of genes related to C/D box small nucleolar RNAs were observed in Fabp7 KO mice. A heat map of these genes is shown in Fig. 5A.
Bioinformatics analysis of DEGs in the WT and Fabp7 KO mouse inner ear
Functional annotation and pathway enrichment analyses of the DEGs were performed using Metascape31. We found no significantly enriched terms in the downregulated DEGs in Fabp7 KO mice. In contrast, “electron transport chain” was the significantly enriched term in the upregulated DEGs in Fabp7 KO mice (Fig. 5B,C). Thus, the expression of mitochondrial function-mediated genes was upregulated or less impaired after noise exposure in the inner ear of Fabp7 KO mice, compared to that in WT mice, implying that mitochondrial activities were more preserved after noise exposure in the cochlea of Fabp7 KO mice.
Identification of variable metabolites in the WT and Fabp7 KO mouse inner ear
To identify the changes in metabolites induced by Fabp7 deletion in the inner ear after noise exposure, we performed metabolomic analysis32,33,34 using WT and Fabp7 KO mouse inner ear one day after noise exposure (a total of 15 analyses using 5 samples for each group) (Fig. 1A). We found 162 metabolites with increased levels and 294 metabolites with reduced levels reliably annotated in Fabp7 KO mice (Supplementary Tables 1 and 2); the data was populated in the enrichment analysis of MetaboAnalyst35.
Bioinformatics analysis of variable metabolites in the WT and Fabp7 KO mouse inner ear
After converting the names of the metabolites to registered names in the latest version of MetaboAnalyst, we finally selected 47 metabolites with increased levels and 67 metabolites with reduced levels in Fabp7 KO mice (Supplementary Tables 3 and 4). We performed functional annotation and pathway enrichment analysis using MetaboAnalyst with the small molecule pathway database36. As a result, metabolites associated with “nucleotide sugars metabolism”, “beta-alanine metabolism”, “galactose metabolism,”, and “phosphatidylcholine biosynthesis” were the significantly enriched terms for increased metabolites in Fabp7 KO mice (Fig. 6A). In contrast, metabolites associated with “aspartate (l-aspartic acid) metabolism”, “urea cycle”, “malate-aspartate shuttle”, and “glutamate (l-glutamic acid) metabolism” were the significantly enriched terms for reduced metabolites in Fabp7 KO mice (Fig. 6B). Quantitative data for representative reduced metabolites in Fabp7 KO mice are shown in Fig. 6C–F. Aspartate and glutamate, representative excitatory transmitters, were significantly lower in the Fabp7 KO mice (Figs. 6C,D, respectively), and ARA, an essential precursor of eicosanoids, were also significantly reduced in Fabp7 KO mice. Collectively, noise exposure induced various metabolic changes such as amino acid and lipid metabolism in the inner ear of Fabp7 KO mice compared to those in WT mice; these metabolic changes may contribute to the hearing-preservation phenotype of Fabp7 KO mice.
Discussion
In this study, we examined the impact of Fabp7 deficiency on hearing following exposure to noise using newly developed genome-edited Fabp7 KO mice with a C57BL/6 background. Our findings demonstrated that Fabp7 deletion remarkably reduced the permanent threshold elevation after noise exposure, thereby preserving the integrity of OHCs and IHCs, particularly in high-frequency regions. Moreover, Fabp7 KO mice exhibited no increase in the levels of toxic oxidized lipids and displayed upregulated or less impaired gene expression associated with electron transport chain function after noise exposure, further substantiating the protective effects associated with Fabp7 deletion. Furthermore, metabolomic analysis revealed notable alterations in the levels of some metabolites, including excitatory neurotransmitters such as glutamate and aspartate.
FABP7 is essential for neuronal and glial cell development, as well as postnatal neural stem cell proliferation, highlighting its importance in the nervous system23,37,38,39,40 and the adverse effects of its deficiency. For example, Fabp7 KO mice have exhibited lower survival of ventral neurons and poorer motor function recovery than WT mice in a spinal cord injury model41. Fabp7 KO mice also exhibit reduced neurogenesis in the dentate gyrus under physiological and ischemia-induced conditions39. In contrast, our study revealed prospective effects of Fabp7 deficiency on cochlear function following noise trauma. Similarly, Fabp7 KO mice have exhibited better final clinical scores than those of WT mice in an experimental autoimmune encephalomyelitis model, although an early deterioration in clinical scores has also been noted42. Other studies have also suggested positive effects of FABP7 deficiency on neurological prognosis; FABP7 upregulation induces a neurotoxic phenotype in an astrocyte-motor neuron co-culture model43, and the administration of an FABP inhibitor reduces brain infarct volumes and neurological deficits in a mouse cerebral ischemia–reperfusion injury model44. Our findings further support the notion that FABP7 exacerbates nerve tissue damage, suggesting a dual role for FABP7 during neurogenesis and physiological states versus tissue damage. This duality might be associated with the involvement of FABP7 in the external stimulus response of astrocytes through the regulation of Caveolin-1 expression, which affects lipid raft function45. Inflammation is a consequential response to external stimuli, and FABP7 overexpression promotes proinflammatory responses in mouse astrocytes43. However, Fabp7 KO mice also exhibit elevated mRNA expression levels of inflammatory cytokines in the spinal cord after inducing experimental autoimmune encephalomyelitis42. Thus, FABP7 deficiency elicits contrasting reactions under various conditions. Although our RNA sequencing and metabolomic analyses did not directly indicate the suppression of inflammatory reactions, noise-exposed Fabp7 KO mice showed a significant decrease in the levels of ARA, a precursor of inflammatory bioactive lipids and eicosanoids. Further investigations into the relationship between noise vulnerability and PUFA metabolites may clarify the pathology of NIHL.
Detrimental effects of noise trauma on the cochlea include mechanical damage to the cochlear structure, reduced blood flow, sterile inflammation, oxidative stress-induced mitochondrial dysfunction, apoptosis, and glutamate excitotoxicity. These pathologies collectively contribute to the development of PTS or temporary threshold shift, depending on severity of the injury3,7,46. Our current study primarily focused on improving hearing ability and cochlear pathology 14 days following acoustic exposure, and assessing its impact on PTS. Interestingly, there were no significant differences in ABR thresholds one day after noise exposure, indicating comparable cochlear damage in both WT and Fabp7 KO mice. However, based on the distinct differences between the two groups observed 14 days following exposure, we hypothesized that Fabp7 deletion mitigates the delayed-onset of harmful effects, including oxidative stress, inflammation, and apoptosis. The expansion of OHC apoptosis and the immune response of cochlea, such as increase in macrophages and neutrophils, occurs several days following noise exposure47,48,49, suggesting that Fabp7 deletion may alleviate these harmful reactions. Although we did not confirm changes in the expression of pro-inflammatory and apoptosis-related genes, reduction in the levels of oxidized lipids and PUFAs in Fabp7 KO mice supports our hypothesis as these compounds can induce oxidative stress and inflammation11. Here, we observed the mitigation of ABR threshold shifts at 8, 12, and 32 kHz in Fabp7 KO mice after noise exposure, but the underlying increase in OHC survival was only confirmed in the 32 kHz region in cochlear wholemounts. Since a loss of stereocilia tip links and metabolic disturbance in the cochlear lymph fluid can cause PTS3, these injury mechanisms may contribute to the change in ABR threshold shifts at 8 and 12 kHz in Fabp7 KO mice.
Interestingly, genes related to the electron transport chain were upregulated or less impaired in the inner ear of noise-exposed Fabp7 KO mice, implying preserved mitochondrial function. Mitochondria play a role in metabolic damage and ROS generation induced by noise trauma50,51; severe mitochondrial damage can trigger mitochondria-mediated apoptosis52. Mice lacking NADH dehydrogenase (ubiquinone) Fe–S protein 4, a subunit of the mitochondrial complex I, have displayed accelerated permanent low-frequency threshold shifts following moderate noise exposure53. Although there is no direct evidence of the mitochondrial protective effect of Fabp7 deficiency, we observed increased expression of genes related to NADH dehydrogenase in noise-exposed Fabp7 KO mouse cochlea. Further investigations focusing on mitochondrial function and detailed mitochondrial histology will contribute to elucidating the mechanism underlying this effect in future studies.
Glutamate excitotoxicity, a cell death mechanism triggered by excessive glutamate release from neurons and glial cells, has been implicated in various neurological disorders54. Excess glutamate can lead to glutathione deficiency, sustained activation of the glutamate receptor in the postsynaptic membrane, and damage to afferent neural fibers8,55. The accumulation of glutamate is associated with acute and chronic deterioration of the auditory nervous system, wherein acoustic overstimulation induces glutamate-induced excitotoxicity in IHCs and type 1 SG neurons8,56,57,58,59. Our study observed an improved survival rate of hair cells in Fabp7 KO mice, possibly due to a significant decrease in glutamate levels within the cochlea in Fabp7 KO mice, compared to those in WT mice. Although FABP7 is expressed in many glial cells of the nervous system and participates in modulating the signaling pathways of glutamatergic synapses, the direct relationship between FABP7 and glutamate metabolism remains unclear. In this study, the expression of Slc1a2, the principal transporter participating in the clearance of glutamate, was increased in the cochlea of noise-exposed Fabp7 KO mice. Interestingly, a recent study has demonstrated a significant decrease in Slc1a2 gene expression in the cochlea 15 days after noise exposure compared to those in control conditions and the first day after noise exposure. These findings emphasize the importance of Slc1a2 in the pathology of noise-induced trauma60. Thus, Fabp7 deficiency leads to an otoprotective phenotype, possibly through the increased expression of glutamate transporters and reduced glutamate levels. We anticipate that further research will advance our understanding of the underlying mechanisms, based on the results of this study.
In this study, we conducted metabolomic analysis of the noise-exposed inner ear tissue. Metabolomics is a state-of-the-art technique enabling the comprehensive analyses of all metabolites in a sample, providing a snapshot of its physiological state61. However, research on the metabolome of inner ear pathologies remains limited61,62, with only a few published studies specifically focusing on mouse samples following noise exposure63,64. One such study by Ji et al. investigated the effect of noise exposure on metabolites in the entire inner ear of CBA/CaJ mice and revealed changes such as increased glutamate and aspartate levels63. Similar to glutamate, aspartate is an excitatory transmitter in the brain, which is released into the cochlea following noise exposure65,66. Interestingly, we observed a significant decrease in glutamate and aspartate levels in the inner ear of noise-exposed Fabp7 KO mice, suggesting a potential role for FABP7 in mitigating excitotoxicity and preserving hearing. Thus, glutamate and aspartate may be critical molecules involved in noise-induced cochlear damage, with FABP7 potentially modulating their levels directly or indirectly. Additionally, we identified other changes, including an increase in nucleotide sugar metabolism, in the inner ear metabolome of noise-exposed Fabp7 KO mice. However, it remains unclear whether these metabolite alterations indicate tissue damage or reparative processes. Further advancements in inner ear metabolomic analyses will provide a more comprehensive understanding of these intricacies.
This study has several limitations. First, we utilized whole inner ear tissue for RNA sequencing and metabolomic analyses. While these methods allow the assessment and quantification of considerable changes in gene expression and metabolites within inner ear tissues, they did not provide detailed insights into cellular changes. In addition, the quality of RNA in this study was sub-optimal. Fortunately, single-cell RNA sequencing of the mouse inner ear has been performed previously, and a cell-type-specific transcriptomic map of the cochlear response to acoustic overexposure is available67. Further investigations should leverage this novel technique for a more comprehensive evaluation. Similarly, metabolomic analysis is still a developing field, and currently, analyses using the entire mouse inner ear are appropriate because of the widespread impact of noise exposure on metabolomes across the intracellular and extracellular inner ear compartments. Second, we used genome-edited Fabp7 KO mice with a C57BL6 background. Hence, the developmental influence of Fabp7 deletion may affect the results of noise exposure experiments initiated at nine weeks of age. Although no difference in ABR thresholds was observed between WT and Fabp7 KO mice prior to noise exposure, elucidating the role of FABP7 in the defense mechanism against noise trauma in adult mice would necessitate experiments using Fabp7 conditional KO mice or the local application of FABP7 inhibitors. Notably, a recent report demonstrated the ameliorative effects of an FABP7 inhibitor on oligodendrocyte injury in a mouse model of multiple sclerosis68 and on cerebellum dysfunction in a multiple-system atrophy mouse model69. Therefore, it would be worthwhile to explore whether such an FABP7 inhibitor could play a protective role against cochlear noise trauma. Third, the protective effect of Fabp7 deletion on hair cells is indirect because it is not expressed in hair cells. Moreover, detailed changes in support cells lacking FABP7 were not extensively evaluated in this study despite the lack of noticeable differences in supporting and non-neuronal cells observed in cochlear sections stained with hematoxylin and eosin (H&E). Future investigations could benefit from employing sophisticated techniques such as primary culture and single-cell RNA sequencing to enable more detailed analyses. Finally, although the gene expression associated with electron transport chain function after noise exposure was upregulated or less impaired in Fabp7 KO mice, this change does not necessarily indicate preservation of mitochondrial function. Evaluation of mitochondrial functions, such as the oxygen consumption rate, using cochlear tissues is yet to be established and remains a future challenge.
In conclusion, our study highlights the benefits of FABP7 deficiency in mitigating cochlear damage following noise exposure. FABP7 expression is specific to non-hair and non-neuronal cells in the cochlea. The observed protective effect of its deletion was supported by the upregulated or less impaired expression of genes involved in the electron transport chain, as well as alterations in several metabolites, including excitotoxic glutamates and aspartates. Notably, FABP7 plays a crucial role in signal regulation in response to external stimuli and may serve as a vital molecule in the mechanisms underlying nervous system trauma, including noise trauma. These findings contribute to our understanding of the complex processes involved in cochlear injury and highlight the potential therapeutic significance of targeting FABP7 in noise-induced damage. Further research in this field may open new avenues for the development of novel strategies to prevent or treat NIHL.
Methods
Animals and experimental protocol
WT and Fabp7 KO mice with a C57BL/6NCrl genetic background, generated using the CRISPR-Cas9 nickase system, were used28. Heterozygous Fabp7 KO mice were crossed, and their offspring were genotyped using polymerase chain reaction (PCR) with the following primers: Fabp7 forward (5′- GGTAAGACCCGAGTTCCTCCAGTT -3′) and Fabp7 reverse (5′-TGAGTGGGCTATGCACAGTCTT-3′). The following cycling conditions were used: 94 °C for 3 min, 35 cycles of 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s, followed by 72 °C for 3 min and 4 °C indefinitely. The PCR products were separated on a 2.2% agarose gel to detect bands of the following expected sizes: 271 bp for the WT and 243 bp for Fabp7 mutant alleles. After obtaining the first generation of WT and homozygous Fabp7 KO mice, crosses were made between each group and their male children were used in the experiment. The mice were housed under a 12 h light–dark cycle at a constant temperature with ad libitum access to food and water. All mice were treated following the guidelines presented in The Standards for Human Care and Use of Laboratory Animals of Tohoku University, Guidelines for Proper Conduct of Animal Experiments by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the National Institute of Health Guide for the Care and Use of Laboratory Animals. Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines were followed. All animal experiments were approved by the Ethics Committee for Animal Experiments of the Tohoku University Graduate School of Medicine (2020-132).
Figure 1A shows a schematic representation of the experimental design. Initial ABR measurements were performed at 9 weeks of age and noise exposure was applied at 10 weeks of age in 8 male WT and Fabp7 KO mice. A second ABR measurement was performed 24 h after noise exposure, with the final measurement and sampling conducted at 12 weeks. Because the cochleae of a Fabp7 KO mouse were damaged during sampling, histological analysis for Fabp7 KO mice was performed on 7 animals. For the analysis of RNA sequencing, 3 WT and Fabp7 KO mice were sampled 24 h after noise exposure at 10 weeks. For the analysis of metabolomics, 5 WT and Fabp7 KO mice were sampled 24 h after noise exposure at 10 weeks. For the histological analysis of oxidative stress, 3 control WT mice, 3 noise-exposed WT mice, and 4 noise-exposed Fabp7 KO mice were sampled 24 h after noise exposure at 10 weeks.
Cdh23 genotyping
Genomic DNA was isolated from WT and Fabp7 KO mice (n = 5 per group) and used as a template to amplify 360-bp regions around the 753rd nucleotide in the Cdh23 gene using PCR. The resultant products were then sequenced70 using the following primers: Cdh23 forward 5′-GATCAAGACAAGACCAGACCTCTGTC-3′ and Cdh23 reverse 5′-GAGCTACCAGGAACAGCTTGGGCCTG-3′. The cycling conditions were as follows: 95 °C for 2 min, 35 cycles of 95 °C for 30 s, 60 °C for 1 min, 72 °C for 1 min, and 72 °C for 5 min.
Cochlear function testing
The ABRs were recorded as described previously26. Mice were anesthetized using an intraperitoneal injection of ketamine (100 mg/kg body weight) and xylazine (20 mg/kg body weight). Needle electrodes were placed subcutaneously at the vertex (active), the base of the pinna (reference), and the back (ground). ABR recordings were performed using the TDT System 3 auditory-evoked potential workstation and BioSigRP software (Tucker-Davis Technologies, Alachua, FL). ABRs were evoked using bursts of pure tone at frequencies of 4, 8, 12, 16, and 32 kHz. The evoked responses were averaged using 1,000 responses for each SPL. Responses were collected for stimulus levels in 5-dB steps from 100 dB SPL to 10 dB SPL. The ABR threshold was defined as the lowest sound level at which a reproducible waveform was confirmed; it was determined by a separate examiner blinded to the genotype. If a mouse showed no response, the stimulus threshold was defined as 105 dB SPL.
Noise exposure
Awake and unrestrained mice were placed in a wire-mesh cage and exposed to 8–16 kHz octave-band noise at 100 dB SPL for 2 h in a sound-exposure box as previously described53. Sound was generated using a waveform generator (SF-06, Random Noise Generator; RION), amplified (D-75A; Crown), filtered (Multifunction Filter; NF Corporation), and delivered by a loudspeaker (2446H; JBL) positioned at the center of the cage. The sound levels were measured using a sound level meter (2250 L; Brüel & Kjær.)
Tissue preparation
Mice were deeply anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (20 mg/kg), and transcardially perfused with 10% formalin neutral buffer solution (pH 7.4) (Wako, Osaka, Japan). The inner ear was quickly removed and immersed in 10% formalin-neutral buffer. Small holes were made in the round and oval windows and the apex of the cochlea. The cochleae were perfused through the cochlear scalae, post-fixed with 10% formalin neutral buffer solution at 4 °C for 16 h, and decalcified in 10% ethylenediaminetetraacetic acid for 2 days at room temperature.
Cochlear wholemount and hair cell counts
After fixation and demineralization, cochlear wholemount was performed as previously described13. Hair cells were stained for F-actin using rhodamine-conjugated phalloidin (1:100, Rhodamine Phalloidin, Thermo Fisher Scientific, Waltham, MA, USA) for 1 h at room temperature. Low-power fluorescence images were obtained using a microscope (BZ-9000, Keyence, Osaka, Japan) and BZ-H1 software (Keyence), and full-length cochlear images were assembled and analyzed using Adobe Photoshop. The ImageJ plug-in was used to create a cochlear frequency map. We counted the losses of IHCs and OHCs in seven frequency-specific regions (4.0, 8.0, 11.3, 16.0, 22.6, 32.0, and 45.2 kHz) of the cochlea. We observed 60 OHCs associated with 20 IHCs using a fluorescence microscope (BZ-9000) with a 40× objective.
Cochlear histology using coronal sections
To detect differences in cochlear histological damage after noise exposure, paraffin Sections (3 μm) were stained with H&E and observed under a light microscope (BZ-9000) separately in the apical, middle, and basal turns. The cell density of SG neurons, type-4 fibrocytes, and the thickness of the SV within each turn were calculated using a 40× objective. The area and cell numbers were determined using the BZ-H1C software. Cell density was calculated by dividing the total number of cells by the measured area and expressed as the number of cells per mm2. For SV thickness, three measurements from the endolymphatic surface of the marginal cells to the spiral ligament side of the basal cells were obtained from each image and averaged. Two sections per animal were used to calculate mean values.
Immunohistochemistry of frozen sections
To prepare frozen sections, decalcified cochleae were treated with 30% sucrose in phosphate-buffered saline (PBS), embedded in Tissue-Tek optimum cutting temperature compound (Sakura Finetek, Tokyo, Japan), frozen, and cut at 10 µm thickness parallel to the modiolus using a CM3050 cryostat (Leica Biosystems, Wetzlar, Germany). Sections were mounted on MAS-coated glass slides (Superfrost; Matsunami Glass, Kishiwada, Japan). After rinsing with PBS, tissue sections were blocked with 3% bovine serum albumin/0.3% Triton X-100/ PBS for 30 min at room temperature, the unconjugated AffiniPure Fab fragment of anti-mouse IgG (1:10, Jackson ImmunoResearch, West Grove, PA) for 2 h at room temperature, and incubated overnight with the following primary antibodies: (1) rabbit IgG anti-FABP7 (1:1000, Merck, Darmstadt, Germany #PRS4259), (2) mouse IgG anti-TUJ-1 (1:500, Abcam, Cambridge, UK #ab78078), (3) mouse IgG2a anti-Myosin 7a (MYO7a) (1:200, Santa Cruz Biotechnology, Dallas, TX, USA #SC-74516), and (4) goat IgG anti-SOX2 (1:500, R&D Systems, Minneapolis, MN, USA #AF2018). Following overnight incubation with the primary antibodies at 4 °C, the sections were rinsed and then incubated with donkey anti-rabbit IgG Alexa Fluor 568 conjugate (1:500, Thermo Fisher Scientific, Waltham, MA, USA #A-10042) and goat anti-mouse IgG2a Alexa Fluor 488 conjugate (1:500, Thermo Fisher Scientific #A-21131), or chicken anti-rabbit IgG Alexa Fluor 647 conjugate (1:500, Thermo Fisher Scientific #A-21443) and donkey anti-mouse IgG Alexa Fluor 568 conjugate (1:500, Thermo Fisher Scientific #A-10037) and donkey anti-goat IgG Alexa Fluor 488 conjugate (1:500, Thermo Fisher Scientific #A-11055) for 1 h at room temperature. The slides were mounted with coverslips using a mounting medium with 4′,6-diamidino-2-phenylindole (VECTASHIELD Mounting Medium with DAPI, Vector Labs #H-1200). For the evaluation of FABP7 expression in the cochleae of WT and Fabp7 KO mice, the slides were imaged using a fluorescence microscope (BZ-9000) and BZ-H1C software for the same exposure time at 20× magnification. For the detailed localization analysis of FABP7 in the cochlea of WT mice, a confocal microscope (TCS SP8, Leica Microsystems, Wetzlar, Germany) fitted with a 63× objective was used. Maximum intensity projection images were created using an image processing software (Leica Application Suite X, Leica Microsystems). The images were merged using Adobe Photoshop (San Jose, CA, USA).
Immunostaining of oxidized fatty acid in cochlear sections
Frozen sections were prepared as described above. After rinsing with PBS, antigen retrieval was performed using microwave irradiation for 15 min in 0.05% citraconic anhydride buffer (Wako #097-06192). Tissue sections were blocked with 3% bovine serum albumin/0.3% Triton X-100/PBS for 30 min at room temperature and incubated overnight with the following primary antibodies: (1) mouse IgG1 anti-4-NHE (1:200, JaICA, Fukuroi, Japan #MHN-100P), (2) mouse IgG1 anti-4-HHE (1:100, JaICA #MHH-030n). Following overnight incubation with the primary antibodies at 4 °C, the sections were rinsed and then incubated with goat anti-mouse IgG1 Alexa Fluor 568 conjugate (1:1000, Thermo Fisher Scientific #A-21124) for 1 h at room temperature. The nuclei were then counterstained with 4′,6-diamidino-2-phenylindole (1:1000; Merck, Darmstadt, Germany #9542), and the slides were mounted with coverslips using a mounting medium (VECTASHIELD Mounting Medium, Vector Labs #H-1000). The slides were imaged using a fluorescence microscope (BZ-9000) for the same exposure time at 40× magnification. The areas and signal intensities of the OC and SG regions were measured at the middle turns using the BZ-H1C analysis software. Two sections per mouse were analyzed and used to calculate the mean values.
RNA extraction and RNA sequencing
RNA extraction and sequencing were performed as previously described53. The inner ears were quickly dissected from the skull and stored at -80 ℃. RNA extraction was performed using RNAiso Plus (Cat# 9180; Takara Bio, Kusatsu, Shiga, Japan), according to the manufacturer’s instructions, with freeze-crushing of the tissues. RNA pellets were dissolved in 30 µL Milli-Q Water (Merck Millipore, Burlington, MA, USA). The RNA integrities of eight samples (WT: n = 3 and Fabp7 KO: n = 3) were determined using the Agilent RNA 600 Nano Kit (Cat# 5067-1511; Agilent Technologies, Santa Clara, CA, USA) on a Bioanalyzer (Agilent Technologies). The mean RNA integrity of all samples was 4.85 ± 0.85. Subsequently, 500 ng of RNA from each sample was used to create libraries using the NEBNext Ultra II RNA Library Prep Kit for Illumina and the NEBNext rRNA Depletion Kit v2 (Cat# E7770S and E7400L; New England Biolabs, Ipswich, MA, USA), according to the manufacturer’s instructions. The duration of the final PCR cycle was 15 min. The concentration and size distribution of the libraries were measured using the Agilent DNA 7500 kit (Cat#5067-1506; Agilent Technologies, Santa Clara, CA, USA) and a bioanalyzer (Agilent Technologies). All samples were analyzed using next-generation sequencing (NGS) equipment. The libraries were pooled and the concentrations were adjusted to 1 nM. The pooled libraries were subjected to denaturation and neutralization assays. Subsequently, the libraries were diluted to 1.8 pM and subjected to NGS run using NextSeq500/550 v2.5 (75 cycles) kits (Cat#20024906; Illumina, San Diego, CA, USA) in the NextSeq 500 System (Illumina). Sequencing was performed using paired-end reads of 36 bases. Following this, FASTQ files were exported, and basic information of the NGS run data was checked using the CLC Genomics Workbench software (version 22.0; QIAGEN, Hilden, Germany). During quality assessment of the reads, a Phred Score > 20 was confirmed for 99.7% of all reads, indicating success of the run.
Bioinformatics analysis for RNA sequencing
The average reads per kilobase of exon per million mapped reads of > 1 and false discovery rate < 0.05 were regarded as DEGs and uploaded to Metascape (https://metascape.org/gp/index.html#/main/step1), which is an open online analysis software that can perform pathway and process enrichment analysis based on numerous ontology sources31.
Metabolomics mass spectrometry
The inner ears were quickly harvested from the skull and stored at − 80 °C. Every tissue (approximately 10–50 mg) was placed in 1.5 mL screw tubes and a twofold (w/v) mixture of water/methanol (1:1, v/v) was added. Two pieces of 2 mm stainless beads were added to the tube, the mixture was shaken at 3,000 rpm for 5 min at room temperature using a beads crusher (TAITEC Co., Saitama, Japan), and centrifugated for 10 min at 15,000×g and 4 ℃.
To prepare study quality control (SQC) sample for metabolomics, every seven microliters of the supernatants were mixed. The SQC mixture or each sample was mixed with an equal volume of formic acid/water (0.1:100, v/v) and analyzed using liquid chromatography-mass spectrometry (LC–MS), wherein 1 μL of the sample aliquot was injected.
For LC–MS metabolomics, a TripleTOF 5600 quadrupole-time of flight hybrid mass spectrometer (SCIEX, Framingham, MA, USA) and a Nexera ultra-high-performance liquid chromatograph system (Shimadzu Co. Ltd., Kyoto, Japan) were used. Measurements were performed in both positive and negative ion modes. Semi-quantitative analysis by measurement and MS Peak processing were performed using Analyst TF version 1.6.0 (SCIEX) and MS-DIAL software71. For LC conditions in both positive and negative ion modes, a mixture of water: 1 M NH4HCO3 in water: 25% aqueous ammonium (99:1:0.1, v/v/v) was used as mobile phase A and acetonitrile was used as mobile phase B. The LC gradient flow was as follows: B (%), 95–5%; 0–10 min. The flow rate was set at 0.4 mL/min. An Agilent HILIC-Z column (150 mm × 2.1 mm i.d., 2.7 µm) was used and the column temperature was set to 40 ºC. Sample solution (1 μL) was injected and the gradient conditions were examined.
Bioinformatics analysis for metabolomics
Raw sample data were deconvoluted, aligned, and annotated using MS-DIAL 4.9 (http://prime.psc.riken.jp/compms/msdial/main.html). The metabolites were annotated using the Human Metabolome Database (https://hmdb.ca/spectra/ms/search) and MS-DIAL databases. We performed a two-tailed t-test to identify metabolites with significant differences between WT and Fabp7 KO mice using Microsoft Excel 2016. In each group, three analyses were performed with five samples each for a total of 15. Differential metabolites were defined as those with p-values < 0.05, and 456 reliably annotated metabolites were retained for downstream analysis. Enrichment analysis was performed using MetaboAnalyst 5.0 (https://www.metaboanalyst.ca/), a comprehensive web-based platform dedicated to metabolomic data analysis35.
Statistical analyses
Statistical analyses were conducted using Prism 9 (GraphPad Software, San Diego, CA, USA) for the unpaired t-test, one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test, and two-way or two-way repeated measures ANOVA followed by Šídák’s multiple comparison test. All data are presented as means ± standard deviation. Statistical significance was set at P < 0.05.
Data availability
The data generated and analyzed in the current study are available from the corresponding author upon reasonable request. The RNA sequencing data have been deposited in Gene Expression Omnibus (GSE241529).
References
Neitzel, R. L. & Fligor, B. J. Risk of noise-induced hearing loss due to recreational sound: Review and recommendations. J. Acoust. Soc. Am. 146, 3911. https://doi.org/10.1121/1.5132287 (2019).
Le, T. N., Straatman, L. V., Lea, J. & Westerberg, B. Current insights in noise-induced hearing loss: A literature review of the underlying mechanism, pathophysiology, asymmetry, and management options. J. Otolaryngol. Head Neck Surg. 46, 41. https://doi.org/10.1186/s40463-017-0219-x (2017).
Natarajan, N., Batts, S. & Stankovic, K. M. Noise-induced hearing loss. J. Clin. Med. https://doi.org/10.3390/jcm12062347 (2023).
Dillard, L. K. et al. Prevalence and global estimates of unsafe listening practices in adolescents and young adults: A systematic review and meta-analysis. BMJ Glob. Health https://doi.org/10.1136/bmjgh-2022-010501 (2022).
Wasano, K., Kaga, K. & Ogawa, K. Patterns of hearing changes in women and men from denarians to nonagenarians. Lancet Reg. Health West. Pac. 9, 100131. https://doi.org/10.1016/j.lanwpc.2021.100131 (2021).
Varela-Nieto, I., Murillo-Cuesta, S., Calvino, M., Cediel, R. & Lassaletta, L. Drug development for noise-induced hearing loss. Expert Opin. Drug Discov. 15, 1457–1471. https://doi.org/10.1080/17460441.2020.1806232 (2020).
Fetoni, A. R., Paciello, F., Rolesi, R., Paludetti, G. & Troiani, D. Targeting dysregulation of redox homeostasis in noise-induced hearing loss: Oxidative stress and ROS signaling. Free Radic. Bio.l Med. 135, 46–59. https://doi.org/10.1016/j.freeradbiomed.2019.02.022 (2019).
Mao, H. & Chen, Y. Noise-induced hearing loss: Updates on molecular targets and potential interventions. Neural Plast. 2021, 4784385. https://doi.org/10.1155/2021/4784385 (2021).
Henderson, D., Bielefeld, E. C., Harris, K. C. & Hu, B. H. The role of oxidative stress in noise-induced hearing loss. Ear Hear. 27, 1–19. https://doi.org/10.1097/01.aud.0000191942.36672.f3 (2006).
Honkura, Y. et al. NRF2 is a key target for prevention of noise-induced hearing loss by reducing oxidative damage of cochlea. Sci. Rep. 6, 19329. https://doi.org/10.1038/srep19329 (2016).
Awada, M. et al. Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J. Lipid Res. 53, 2069–2080. https://doi.org/10.1194/jlr.M026179 (2012).
Martinez-Vega, R. et al. Long-term omega-3 fatty acid supplementation prevents expression changes in cochlear homocysteine metabolism and ameliorates progressive hearing loss in C57BL/6J mice. J. Nutr. Biochem. 26, 1424–1433. https://doi.org/10.1016/j.jnutbio.2015.07.011 (2015).
Honkura, Y. et al. Effects of enriched endogenous omega-3 fatty acids on age-related hearing loss in mice. BMC Res. Notes 12, 768. https://doi.org/10.1186/s13104-019-4809-8 (2019).
Gopinath, B., Flood, V. M., Rochtchina, E., McMahon, C. M. & Mitchell, P. Consumption of omega-3 fatty acids and fish and risk of age-related hearing loss. Am. J. Clin. Nutr. 92, 416–421. https://doi.org/10.3945/ajcn.2010.29370 (2010).
Dullemeijer, C. et al. Plasma very long-chain n-3 polyunsaturated fatty acids and age-related hearing loss in older adults. J. Nutr. Health Aging 14, 347–351. https://doi.org/10.1007/s12603-010-0078-x (2010).
Haubner, L. Y. et al. Maternal dietary docosahexanoic acid content affects the rat pup auditory system. Brain Res. Bull. 58, 1–5. https://doi.org/10.1016/s0361-9230(01)00764-x (2002).
Church, M. W. et al. Excess omega-3 fatty acid consumption by mothers during pregnancy and lactation caused shorter life span and abnormal ABRs in old adult offspring. Neurotoxicol. Teratol. 32, 171–181. https://doi.org/10.1016/j.ntt.2009.09.006 (2010).
Long, L., Jia, Z. & Tang, X. Serum polyunsaturated fatty acids and hearing threshold shifts in adults in the United States: A cross-sectional study. Front. Public Health 10, 939827. https://doi.org/10.3389/fpubh.2022.939827 (2022).
Yevenes-Briones, H. et al. Dietary fat intake and risk of disabling hearing impairment: A prospective population-based cohort study. Eur. J. Nutr. 61, 231–242. https://doi.org/10.1007/s00394-021-02644-7 (2022).
Orlando, M. S. et al. Association of audiometric measures with plasma long chain polyunsaturated fatty acids in a high-fish eating population: The Seychelles Child Development Study. Neurotoxicology 77, 137–144. https://doi.org/10.1016/j.neuro.2020.01.005 (2020).
Furuhashi, M. & Hotamisligil, G. S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Drug Discov. 7, 489–503. https://doi.org/10.1038/nrd2589 (2008).
Storch, J. & Thumser, A. E. Tissue-specific functions in the fatty acid-binding protein family. J. Biol. Chem. 285, 32679–32683. https://doi.org/10.1074/jbc.R110.135210 (2010).
Storch, J. & Corsico, B. The multifunctional family of mammalian fatty acid-binding proteins. Annu. Rev. Nutr. 43, 25–54. https://doi.org/10.1146/annurev-nutr-062220-112240 (2023).
Kagawa, Y. et al. Role of FABP7 in tumor cell signaling. Adv. Biol. Regul. 71, 206–218. https://doi.org/10.1016/j.jbior.2018.09.006 (2019).
Saino-Saito, S. et al. Localization of fatty acid binding proteins (FABPs) in the cochlea of mice. Ann. Anat. 192, 210–214. https://doi.org/10.1016/j.aanat.2010.06.007 (2010).
Suzuki, J. et al. “Passenger gene” problem in transgenic C57BL/6 mice used in hearing research. Neurosci. Res. 158, 6–15. https://doi.org/10.1016/j.neures.2019.10.007 (2020).
Suzuki, J. et al. Preservation of cochlear function in Fabp3 (H-Fabp) knockout mice. Neurosci. Res. 81–82, 64–68. https://doi.org/10.1016/j.neures.2014.02.003 (2014).
Evaluation of the role of fatty acid-binding protein 7 in controlling schizophrenia-relevant phenotypes using newly established knockout mice. Schizophrenia Research 217, 52–59. https://doi.org/10.1016/j.schres.2019.02.002 (2020).
Toyokuni, S. et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 359, 189–191. https://doi.org/10.1016/0014-5793(95)00033-6 (1995).
Van Kuijk, F. J., Holte, L. L. & Dratz, E. A. 4-Hydroxyhexenal: A lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta 1043, 116–118. https://doi.org/10.1016/0005-2760(90)90118-h (1990).
Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https://doi.org/10.1038/s41467-019-09234-6 (2019).
Sato, T. et al. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma. Int. J. Cancer 145, 484–493. https://doi.org/10.1002/ijc.32115 (2019).
Saigusa, D. et al. Establishment of protocols for global metabolomics by LC–MS for biomarker discovery. PLoS ONE 11, e0160555. https://doi.org/10.1371/journal.pone.0160555 (2016).
Iwahori, A. et al. Global metabolomics analysis of serum from patients with Niemann-Pick disease type C. Med. Mass Spectrom. 4, 76–86. https://doi.org/10.24508/mms.2020.06.006 (2020).
Xia, J. & Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743–760. https://doi.org/10.1038/nprot.2011.319 (2011).
Jewison, T. et al. SMPDB 2.0: Big improvements to the small molecule pathway database. Nucleic Acids Res. 42, D478-484. https://doi.org/10.1093/nar/gkt1067 (2014).
Arai, Y. et al. Role of Fabp7, a downstream gene of Pax6, in the maintenance of neuroepithelial cells during early embryonic development of the rat cortex. J. Neurosci. 25, 9752–9761. https://doi.org/10.1523/JNEUROSCI.2512-05.2005 (2005).
Matsumata, M. et al. The effects of Fabp7 and Fabp5 on postnatal hippocampal neurogenesis in the mouse. Stem Cells 30, 1532–1543. https://doi.org/10.1002/stem.1124 (2012).
Kato, T., Yoshioka, H., Owada, Y. & Kinouchi, H. Roles of fatty acid binding protein 7 in ischemic neuronal injury and ischemia-induced neurogenesis after transient forebrain ischemia. Brain Res. 1736, 146795. https://doi.org/10.1016/j.brainres.2020.146795 (2020).
Yamamoto, Y. & Owada, Y. Possible involvement of fatty acid binding proteins in psychiatric disorders. Anat. Sci. Int. 96, 333–342. https://doi.org/10.1007/s12565-020-00598-0 (2021).
Senbokuya, N., Yoshioka, H., Yagi, T., Owada, Y. & Kinouchi, H. Effects of FABP7 on functional recovery after spinal cord injury in adult mice. J. Neurosurg. Spine https://doi.org/10.3171/2019.2.SPINE18844 (2019).
Kamizato, K. et al. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis. Neuroscience 409, 120–129. https://doi.org/10.1016/j.neuroscience.2019.03.050 (2019).
Killoy, K. M., Harlan, B. A., Pehar, M. & Vargas, M. R. FABP7 upregulation induces a neurotoxic phenotype in astrocytes. Glia 68, 2693–2704. https://doi.org/10.1002/glia.23879 (2020).
Guo, Q. et al. Fatty acid-binding proteins aggravate cerebral ischemia-reperfusion injury in mice. Biomedicines https://doi.org/10.3390/biomedicines9050529 (2021).
Kagawa, Y. et al. Fatty acid-binding protein 7 regulates function of caveolae in astrocytes through expression of caveolin-1. Glia 63, 780–794. https://doi.org/10.1002/glia.22784 (2015).
Wagner, E. L. & Shin, J. B. Mechanisms of hair cell damage and repair. Trends Neurosci. 42, 414–424. https://doi.org/10.1016/j.tins.2019.03.006 (2019).
Hu, B. H., Henderson, D. & Nicotera, T. M. Involvement of apoptosis in progression of cochlear lesion following exposure to intense noise. Hear. Res. 166, 62–71. https://doi.org/10.1016/s0378-5955(02)00286-1 (2002).
He, W., Yu, J., Sun, Y. & Kong, W. Macrophages in noise-exposed cochlea: Changes, regulation and the potential role. Aging Dis. 11, 191–199. https://doi.org/10.14336/AD.2019.0723 (2020).
Rai, V. et al. The immune response after noise damage in the cochlea is characterized by a heterogeneous mix of adaptive and innate immune cells. Sci. Rep. 10, 15167. https://doi.org/10.1038/s41598-020-72181-6 (2020).
Fujimoto, C. & Yamasoba, T. Mitochondria-targeted antioxidants for treatment of hearing loss: A systematic review. Antioxidants (Basel) https://doi.org/10.3390/antiox8040109 (2019).
Spoendlin, H. Primary structural changes in the organ of Corti after acoustic overstimulation. Acta Otolaryngol. 71, 166–176. https://doi.org/10.3109/00016487109125346 (1971).
Vicente-Torres, M. A. & Schacht, J. A BAD link to mitochondrial cell death in the cochlea of mice with noise-induced hearing loss. J. Neurosci. Res. 83, 1564–1572. https://doi.org/10.1002/jnr.20832 (2006).
Hemmi, T. et al. Effects of Ndufs4 deletion on hearing after various acoustic exposures. Tohoku J. Exp. Med. https://doi.org/10.1620/tjem.2023.J031 (2023).
Belov Kirdajova, D., Kriska, J., Tureckova, J. & Anderova, M. Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells. Front. Cell Neurosci. 14, 51. https://doi.org/10.3389/fncel.2020.00051 (2020).
Chamorro, A., Dirnagl, U., Urra, X. & Planas, A. M. Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol. 15, 869–881. https://doi.org/10.1016/S1474-4422(16)00114-9 (2016).
Hakuba, N., Koga, K., Gyo, K., Usami, S. I. & Tanaka, K. Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J. Neurosci. 20, 8750–8753. https://doi.org/10.1523/JNEUROSCI.20-23-08750.2000 (2000).
Kim, K. X. et al. Vesicular glutamatergic transmission in noise-induced loss and repair of cochlear ribbon synapses. J. Neurosci. 39, 4434–4447. https://doi.org/10.1523/JNEUROSCI.2228-18.2019 (2019).
Liberman, M. C. & Kujawa, S. G. Cochlear synaptopathy in acquired sensorineural hearing loss: Manifestations and mechanisms. Hear. Res. 349, 138–147. https://doi.org/10.1016/j.heares.2017.01.003 (2017).
Sahley, T. L., Anderson, D. J., Hammonds, M. D., Chandu, K. & Musiek, F. E. Evidence for a dynorphin-mediated inner ear immune/inflammatory response and glutamate-induced neural excitotoxicity: An updated analysis. J. Neurophysiol. 122, 1421–1460. https://doi.org/10.1152/jn.00595.2018 (2019).
Cerrah Gunes, M. et al. Change in gene expression levels of GABA, glutamate and neurosteroid pathways due to acoustic trauma in the cochlea. J. Neurogenet. 35, 45–57. https://doi.org/10.1080/01677063.2021.1904922 (2021).
Boullaud, L., Blasco, H., Trinh, T. T. & Bakhos, D. Metabolomic studies in inner ear pathologies. Metabolites https://doi.org/10.3390/metabo12030214 (2022).
Fujita, T. et al. Metabolomic profiling in inner ear fluid by gas chromatography/mass spectrometry in guinea pig cochlea. Neurosci. Lett. 606, 188–193. https://doi.org/10.1016/j.neulet.2015.09.001 (2015).
Ji, L. et al. Auditory metabolomics, an approach to identify acute molecular effects of noise trauma. Sci. Rep. 9, 9273. https://doi.org/10.1038/s41598-019-45385-8 (2019).
Miao, L., Zhang, J., Yin, L. & Pu, Y. Metabolomics analysis reveals alterations in cochlear metabolic profiling in mice with noise-induced hearing loss. Biomed. Res. Int. 2022, 9548316. https://doi.org/10.1155/2022/9548316 (2022).
Jager, W. et al. Noise-induced aspartate and glutamate efflux in the guinea pig cochlea and hearing loss. Exp. Brain Res. 134, 426–434. https://doi.org/10.1007/s002210000470 (2000).
Usami, S. & Ottersen, O. P. Aspartate is enriched in sensory cells and subpopulations of non-neuronal cells in the guinea pig inner ear: A quantitative immunoelectron microscopic analysis. Brain Res. 742, 43–49. https://doi.org/10.1016/s0006-8993(96)01001-3 (1996).
Milon, B. et al. A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma. Cell Rep. 36, 109758. https://doi.org/10.1016/j.celrep.2021.109758 (2021).
Cheng, A., Jia, W., Kawahata, I. & Fukunaga, K. A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models. EBioMedicine 72, 103582. https://doi.org/10.1016/j.ebiom.2021.103582 (2021).
Cheng, A. et al. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model. Acta Pharmacol. Sin. https://doi.org/10.1038/s41401-023-01138-y (2023).
Han, C. et al. Sirt1 deficiency protects cochlear cells and delays the early onset of age-related hearing loss in C57BL/6 mice. Neurobiol. Aging 43, 58–71. https://doi.org/10.1016/j.neurobiolaging.2016.03.023 (2016).
Tsugawa, H. et al. A lipidome atlas in MS-DIAL 4. Nat Biotechnol 38, 1159–1163. https://doi.org/10.1038/s41587-020-0531-2 (2020).
Acknowledgements
We are grateful to Dr. T. Yoshikawa and Dr. H. Miyazaki for providing the Fabp7 knockout mice. We thank Dr. T. Sugasawa for contributing to the RNA sequencing and bioinformatics analysis and Ms. N. Shibata for contributing to the histological analyses. We thank Editage (www.editage.jp) for the English language editing. This work was supported by JSPS KAKENHI [grant numbers JP19K18792 (J.S.), JP22K09700 (J.S.), and JP21K16825 (T.O.)].
Author information
Authors and Affiliations
Contributions
J.S. designed the research; J.S., T.H., and H.I. performed the electrophysiological and histological experiments; M.M. and M.W. performed the metabolomic analysis; H.I., T.O., R. I., Y.H., Y.K., T.K, N.M., Y.O., N.O., and Y.K. contributed to the materials; and J.S. performed the analysis and interpretation of the data. Y. K. supervised the study. J. S. and N. O. wrote the manuscript. All the authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Suzuki, J., Hemmi, T., Maekawa, M. et al. Fatty acid binding protein type 7 deficiency preserves auditory function in noise-exposed mice. Sci Rep 13, 21494 (2023). https://doi.org/10.1038/s41598-023-48702-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-48702-4
- Springer Nature Limited